Patients tracking the landscape for branded tirzepatide products such as Zepbound, or oral semaglutide options such as Rybelsus, can also review our insurance coverage checker and FAQ for province-specific details
Brand-name medications like Ozempic and Wegovy include substantial manufacturing, marketing, and research costs reflected in retail pricing ($900-$1,400/month)
Precision Testing Measures oxalate and amino-acidrelated metabolites tied to metabolic strain or imbalance
The SURMOUNT-OSA trial demonstrated: Mean AHI reduction of approximately 25 to 30 events per hour at 15 mg tirzepatide Significant percentage of patients moving from severe to mild OSA classification Effects observed in both CPAP-using and non-CPAP-using populations Concurrent weight loss consistent with SURMOUNT-1 outcomes Coverage under the OSA pathway has expanded steadily through 2025 and into 2026 across OptumRx-administered plans
For individuals with fatty liver disease or significant insulin resistance, this additional pathway could be meaningful
At Peak Performance in Johnson City, were upfront about its regulatory status and offer it only to appropriate candidates after thorough evaluation